Switching to a Protease Inhibitor-Containing, Nucleoside-Sparing Regimen (Lopinavir/Ritonavir Plus Efavirenz) Increases Limb Fat But Raises Serum Lipid Levels: Results of a Prospective Randomized Trial (AIDS Clinical Trial Group 5125s)
暂无分享,去创建一个
A. Collier | S. Evans | M. Fischl | C. Shikuma | P. Tebas | J. Feinberg | Jiameng Zhang | B. Brizz | F. Sattler | A. Shevitz | Kevin Yarasheski | Barbara Brizz